- Home
- Publications
- Publication Search
- Publication Details
Title
Evidence-Based Treatment of Diabetic Macular Edema
Authors
Keywords
-
Journal
Seminars in Ophthalmology
Volume 32, Issue 1, Pages 56-66
Publisher
Informa UK Limited
Online
2017-01-07
DOI
10.1080/08820538.2016.1228388
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema
- (2016) Susan B. Bressler et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Treatment strategies for refractory diabetic macular edema: switching anti-VEGF treatments, adopting corticosteroid-based treatments, and combination therapy
- (2016) Rehan M. Hussain et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
- (2016) John A. Wells et al. OPHTHALMOLOGY
- Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort
- (2016) et al. JAMA Ophthalmology
- Diabetic Macular Edema: Options for Adjunct Therapy
- (2015) Pilar Calvo et al. DRUGS
- Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes—Protocol 3 with high dose)
- (2015) D V Do et al. EYE
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Dyslipidemia and Diabetic Macular Edema
- (2015) Radha Das et al. OPHTHALMOLOGY
- Intravitreal Aflibercept for Diabetic Macular Edema
- (2015) David M. Brown et al. OPHTHALMOLOGY
- Treatment of Diabetic Macular Edema with an Inhibitor of Vascular Endothelial-Protein Tyrosine Phosphatase That Activates Tie2
- (2015) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: 5-Year Randomized Trial Results
- (2015) Michael J. Elman et al. OPHTHALMOLOGY
- MICROPERIMETRIC ASSESSMENT OF RETINAL SENSITIVITY IN EYES WITH DIABETIC MACULAR EDEMA FROM A PHASE 2 STUDY OF INTRAVITREAL AFLIBERCEPT
- (2015) Victor H. Gonzalez et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- The clinical utility of aflibercept for diabetic macular edema
- (2015) Michael W. Stewart Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular Edema
- (2014) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- A Randomized Clinical Trial of Intravitreal Bevacizumab versus Intravitreal Dexamethasone for Diabetic Macular Edema
- (2014) Mark C. Gillies et al. OPHTHALMOLOGY
- Vision-Related Function after Ranibizumab Treatment for Diabetic Macular Edema
- (2014) Neil M. Bressler et al. OPHTHALMOLOGY
- Intravitreal Aflibercept for Diabetic Macular Edema
- (2014) Jean-François Korobelnik et al. OPHTHALMOLOGY
- Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema
- (2014) David S. Boyer et al. OPHTHALMOLOGY
- Sustained Delivery Fluocinolone Acetonide Vitreous Implants
- (2014) José Cunha-Vaz et al. OPHTHALMOLOGY
- The Effects of Medical Management on the Progression of Diabetic Retinopathy in Persons with Type 2 Diabetes
- (2014) Emily Y. Chew et al. OPHTHALMOLOGY
- Diabetic Retinopathy and Other Ocular Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
- (2013) Lloyd Paul Aiello et al. DIABETES CARE
- Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials
- (2013) David M. Brown et al. OPHTHALMOLOGY
- Anti-vascular endothelial growth factor therapy for diabetic macular edema
- (2013) David S. Boyer et al. Therapeutic Advances in Endocrinology and Metabolism
- A 2-Year Prospective Randomized Controlled Trial of Intravitreal Bevacizumab or Laser Therapy (BOLT) in the Management of Diabetic Macular Edema
- (2012) Ranjan Rajendram et al. ARCHIVES OF OPHTHALMOLOGY
- Current Epidemiology of Diabetic Retinopathy and Diabetic Macular Edema
- (2012) Jie Ding et al. Current Diabetes Reports
- Ranibizumab for Diabetic Macular Edema
- (2012) Quan Dong Nguyen et al. OPHTHALMOLOGY
- Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema
- (2012) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment
- (2012) Michael J. Elman et al. OPHTHALMOLOGY
- Ranibizumab for Edema of the Macula in Diabetes Study
- (2012) Diana V. Do JAMA Ophthalmology
- Bevacizumab and ovarian cancer
- (2012) Agustin Garcia et al. Therapeutic Advances in Medical Oncology
- Targeted therapy with bevacizumab (Avastin) for metastatic colorectal cancer
- (2011) Georgios V. Koukourakis et al. Clinical & Translational Oncology
- Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy
- (2011) David Preiss JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
- (2011) Michael J. Elman et al. OPHTHALMOLOGY
- Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: A 3-Year Multicenter, Randomized, Controlled Clinical Trial
- (2011) P. Andrew Pearson et al. OPHTHALMOLOGY
- Long-term Benefit of Sustained-Delivery Fluocinolone Acetonide Vitreous Inserts for Diabetic Macular Edema
- (2011) Peter A. Campochiaro et al. OPHTHALMOLOGY
- The RESTORE Study
- (2011) Paul Mitchell et al. OPHTHALMOLOGY
- Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study
- (2010) P. Massin et al. DIABETES CARE
- Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
- (2010) Quan Dong Nguyen et al. OPHTHALMOLOGY
- Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
- (2010) Michael J. Elman et al. OPHTHALMOLOGY
- A Prospective Randomized Trial of Intravitreal Bevacizumab or Laser Therapy in the Management of Diabetic Macular Edema (BOLT Study)
- (2010) Michel Michaelides et al. OPHTHALMOLOGY
- Blood-retina barrier permeability in diabetes during acute ACE-inhibition
- (2009) Claus B. Engler et al. ACTA OPHTHALMOLOGICA
- The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: The Twenty-five-Year Incidence of Macular Edema in Persons with Type 1 Diabetes
- (2009) Ronald Klein et al. OPHTHALMOLOGY
- Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema
- (2009) J. Fernando Arevalo et al. OPHTHALMOLOGY
- Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Vitreous Inflammatory Factors with Diabetic Macular Edema
- (2008) Hideharu Funatsu et al. OPHTHALMOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started